Organization · Venture Capital
OTV
OTV, also known as Olive Tree Ventures, is a venture capital firm focused on mid-growth digital health startups, primarily investing in Series A and later stages. The firm operates globally with offices in New York, Tel Aviv, Montreal, and Shanghai.
Overview
What OTV does
What OTV is
OTV, also known as Olive Tree Ventures, is a venture capital firm focused on mid-growth digital health startups, primarily investing in Series A and later stages. The firm operates globally with offices in New York, Tel Aviv, Montreal, and Shanghai.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2015
- Approximate age
- About 11 years
- Structured capabilities
- Funder
- Last reviewed
- April 24, 2026
Official channels
Find OTV elsewhere
Open the official website or a supported primary organization account.
Capability profile
OTV as a funder
Investment thesis
OTV focuses on growth-stage digital health investments, particularly supporting Israeli health-tech founders in their commercialization efforts across the US, Latin America, and Asia-Pacific.
Focus narrative
OTV invests in mid to growth stage startups within the digital health sector, targeting companies that are Series A or later. The fund seeks entrepreneurs with innovative ideas that address real-world healthcare problems and have viable business models, particularly those demonstrating game-changing innovations.
Value beyond capital
OTV adds value by helping portfolio companies reach maturity, refine execution, navigate regulatory environments (especially FDA), and build a global commercial presence. The team leverages their extensive experience in healthcare, technology, and private equity to support startups in achieving their goals.
Terms and economics
- Typical check
- $1,000,000–$10,000,000
- Sweet spot
- $5,000,000
Focus and fit
- Stages
- Series A · Series A+ · Series B · Series B+ · Series C · Series C+ · Growth Equity
- Regions
- Global · North America · Europe · Asia
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 29
- Recorded notable exits
- Lemonaid Health, Atrica, CFR Pharmaceuticals, Dynamic Yield, Nutranext, and Ice.com
Portfolio context
Notable portfolio companies include: mPharma: Focuses on making medicine accessible and affordable (Active). TytoCare: AI-enabled remote physical exam / telemedicine device (FDA-cleared). Lemonaid Health: Telehealth and online pharmacy (exited to 23andMe in 2021). Emedgene: AI-powered genomic interpretation (acquired by Illumina). Scopio Labs: AI-based digital pathology / hematology. Atrica: Mobile infrastructure platform for service providers (Acquired by Nokia).
Common questions
What to know about OTV
Upseed classifies OTV under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 24, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.